​

Taysha Gene Therapies Ownership | Who Owns Taysha Gene Therapies?

OverviewForecastRevenueFinancialsChartTranscripts

Taysha Gene Therapies Ownership Summary

Taysha Gene Therapies is owned by 58.59% institutional investors, 17.54% insiders, and 23.87% retail investors. Fmr is the largest institutional shareholder, holding 9.17% of TSHA shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.18% of its assets in Taysha Gene Therapies shares.

TSHA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTaysha Gene Therapies58.59%17.54%23.87%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr21.21M9.17%$47.51M
Rtw investments, lp18.80M8.13%$42.11M
Avoro capital advisors18.65M8.06%$41.78M
Blackrock11.74M5.08%$26.30M
Ra capital management10.87M4.70%$24.35M
Vr adviser9.00M3.89%$20.16M
Morgan stanley7.48M3.23%$16.75M
Vanguard group7.17M3.10%$16.05M
Octagon capital advisors lp4.57M1.98%$10.24M
Artal group4.35M1.88%$9.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Acuta capital partners2.33M4.40%$5.22M
Tybourne capital management (hk)3.70M1.69%$8.29M
Octagon capital advisors lp4.57M1.61%$10.24M
Vr adviser9.00M1.28%$20.16M
Ghost tree capital1.25M0.88%$2.80M
Rtw investments, lp18.80M0.65%$42.11M
Quantum private wealth730.52K0.58%$1.64M
Avoro capital advisors18.65M0.56%$41.78M
Sands capital ventures724.87K0.54%$1.62M
Ra capital management10.87M0.32%$24.35M

Top Buyers

HolderShares% AssetsChange
Blackrock11.74M0.00%9.15M
State street3.32M0.00%2.98M
Jpmorgan chase2.96M0.00%2.87M
Deutsche bank ag\2.54M0.00%2.54M
Morgan stanley7.48M0.00%2.31M

Top Sellers

HolderShares% AssetsChange
Eversept partners, lp---2.33M
Eagle asset management---1.72M
Cowen and company---1.55M
Point72 asset management---1.11M
Stempoint capital lp---1.09M

New Positions

HolderShares% AssetsChangeValue
Deutsche bank ag\2.54M0.00%2.54M$5.68M
Nuveen asset management1.08M0.00%1.08M$2.42M
Woodline partners lp1.03M0.02%1.03M$2.30M
Granahan investment management809.69K0.07%809.69K$1.81M
Invesco397.75K0.00%397.75K$890.96K

Sold Out

HolderChange
Aquatic capital management-400.00
State of wyoming-1.80K
Headlands-2.31K
Lazard asset management-5.80K
Macquarie group-8.07K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202412012.15%156,916,875-0.74%581.25%7515.38%16-11.11%
Jun 30, 2024107-3.60%158,086,76812.80%681.86%65-1.52%18-28.00%
Mar 31, 202411124.72%140,142,3937.72%600.48%6613.79%25108.33%
Dec 31, 20238939.06%130,103,2670.12%1121.05%5823.40%12100.00%
Sep 30, 20236464.10%129,946,200849.52%10322.78%47327.27%6-50.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S6.52M3.18%38.48K
Fidelity Growth Compy Commingled Pl O6.48M3.16%-
Vanguard Total Stock Mkt Idx Inv4.85M2.37%391.40K
Fidelity Select Biotechnology4.72M2.30%-2.10M
iShares Russell 2000 ETF4.47M2.18%-10.04K
Fidelity Growth Company Fund4.32M2.11%-9.18K
Polar Capital Biotech S Inc3.00M1.46%-
Xtrackers MSCI World Swap ETF 1C2.47M1.20%-
Vanguard Institutional Extnd Mkt Idx Tr2.18M1.06%-5.86K
Fidelity Growth Company K61.70M0.83%-29.30K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 27, 2024Manning Paul B-Buy$3.00M
Nov 17, 2023Manning Paul B-Buy$163.00K
Aug 24, 2023Alam Kamran Chief Financial OfficerSell$76.89K
Aug 16, 2023Manning Paul B-Buy$14.82M
Aug 16, 2023Stalfort John A III-Buy$350.00K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1--
2023 Q41-
2023 Q353
2023 Q214

TSHA Ownership FAQ

Who Owns Taysha Gene Therapies?

Taysha Gene Therapies shareholders are primarily institutional investors at 58.59%, followed by 17.54% insiders and 23.87% retail investors. The average institutional ownership in Taysha Gene Therapies's industry, Biotech Stocks , is 47.04%, which Taysha Gene Therapies exceeds.

Who owns the most shares of Taysha Gene Therapies?

Taysha Gene Therapies’s largest shareholders are Fmr (21.21M shares, 9.17%), Rtw investments, lp (18.8M shares, 8.13%), and Avoro capital advisors (18.65M shares, 8.06%). Together, they hold 25.37% of Taysha Gene Therapies’s total shares outstanding.

Does Blackrock own Taysha Gene Therapies?

Yes, BlackRock owns 5.08% of Taysha Gene Therapies, totaling 11.74M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.3M$. In the last quarter, BlackRock increased its holdings by 9.15M shares, a 352.10% change.

Who is Taysha Gene Therapies’s biggest shareholder by percentage of total assets invested?

Acuta capital partners is Taysha Gene Therapies’s biggest shareholder by percentage of total assets invested, with 4.40% of its assets in 2.33M Taysha Gene Therapies shares, valued at 5.22M$.

Who is the top mutual fund holder of Taysha Gene Therapies shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Taysha Gene Therapies shares, with 3.18% of its total shares outstanding invested in 6.52M Taysha Gene Therapies shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools